Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2004

Yemelyanova AV, Winter W, Seidman JD. Venous thrombosis in the broad ligament: is it a predictor of postoperative pulmonary embolism in gynecological cancer patients? A case-control study. Int J Gynecol Pathol. 2004;23(2):176-9.

Yu JJ, Brennan M, Christos P, Osborne MP, Hoda S, Simmons RM. Bone marrow micrometastases and adjuvant treatment of breast cancer. Breast J. 2004;10(3):181-5.

J Cohen C, Scott DK, Miller J, Zhang J, Zhou P, Larson JE. Transient in utero knockout (TIUKO) of C-MYC affects late lung and intestinal development in the mouse. BMC Dev Biol. 2004;4:4.

Korkmaz CG, Korkmaz KS, Manola J, Xi Z, Risberg B, Danielsen H, et al. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J Urol. 2004;172(3):1134-9.

Paik J-, Skoura A, Chae S-, Cowan AE, Han DK, Proia RL, et al. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev. 2004;18(19):2392-403.

Morales G, Linares JF, Beloso A, Albar JP, Martinez JL, Rojo F. The Pseudomonas putida Crc global regulator controls the expression of genes from several chromosomal catabolic pathways for aromatic compounds. J Bacteriol. 2004;186(5):1337-44.

Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen D-, et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res. 2004;10(3):828-39.

Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell. 2004;6(2):303-9.

Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med. 2004;10(6):594-601.

Hoda SA, Harigopal M. Distinctive calcific deposits in pregnancy-like hyperplasia. Breast J. 2004;10(6):551.